Last reviewed · How we verify
BIVV009 7.5 grams
At a glance
| Generic name | BIVV009 7.5 grams |
|---|---|
| Sponsor | Bioverativ, a Sanofi company |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BIVV009 7.5 grams CI brief — competitive landscape report
- BIVV009 7.5 grams updates RSS · CI watch RSS
- Bioverativ, a Sanofi company portfolio CI